Rituximab for the treatment of multiple sclerosis: a reviewClara Grazia Chisari, Francesco Patti|Journal of Neurology|2021Cited by 204
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinionMassimo Filippi, María Trojano, Maria Pia Amato et al.|Journal of Neurology|2022Cited by 187
Identifying the Distinct Cognitive Phenotypes in Multiple SclerosisErmelinda De Meo, Maria Pia Amato, Emilio Portaccio et al.|JAMA Neurology|2021Cited by 183
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort studyEmilio Portaccio, Maria Pia Amato, Mattia Fonderico et al.|Brain|2022Cited by 158
Effects of a short outpatientrehabilitation treatment on disability of multiple sclerosispatientsFrancesco Patti, Alan J. Thompson, Maria Rita Ciancio et al.|Journal of Neurology|2003Cited by 99